Logo image of CNNE

CANNAE HOLDINGS INC (CNNE) Stock Fundamental Analysis

NYSE:CNNE - New York Stock Exchange, Inc. - US13765N1072 - Common Stock - Currency: USD

17.16  +0.33 (+1.96%)

After market: 17.16 0 (0%)

Fundamental Rating

3

CNNE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 101 industry peers in the Financial Services industry. While CNNE seems to be doing ok healthwise, there are quite some concerns on its profitability. CNNE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

CNNE had negative earnings in the past year.
CNNE had a negative operating cash flow in the past year.
CNNE had negative earnings in 4 of the past 5 years.
In the past 5 years CNNE always reported negative operating cash flow.
CNNE Yearly Net Income VS EBIT VS OCF VS FCFCNNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

1.2 Ratios

CNNE's Return On Assets of -13.67% is on the low side compared to the rest of the industry. CNNE is outperformed by 90.10% of its industry peers.
With a Return On Equity value of -16.59%, CNNE is not doing good in the industry: 87.13% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -13.67%
ROE -16.59%
ROIC N/A
ROA(3y)-13.01%
ROA(5y)-1.54%
ROE(3y)-15.27%
ROE(5y)-1.43%
ROIC(3y)N/A
ROIC(5y)N/A
CNNE Yearly ROA, ROE, ROICCNNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

CNNE has a Gross Margin (17.97%) which is comparable to the rest of the industry.
CNNE's Gross Margin has improved in the last couple of years.
CNNE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.75%
GM growth 5Y3.28%
CNNE Yearly Profit, Operating, Gross MarginsCNNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

5

2. Health

2.1 Basic Checks

CNNE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CNNE has less shares outstanding
CNNE has less shares outstanding than it did 5 years ago.
CNNE has a worse debt/assets ratio than last year.
CNNE Yearly Shares OutstandingCNNE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CNNE Yearly Total Debt VS Total AssetsCNNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

CNNE has an Altman-Z score of 2.08. This is not the best score and indicates that CNNE is in the grey zone with still only limited risk for bankruptcy at the moment.
CNNE's Altman-Z score of 2.08 is fine compared to the rest of the industry. CNNE outperforms 75.25% of its industry peers.
CNNE has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.07, CNNE belongs to the best of the industry, outperforming 83.17% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z 2.08
ROIC/WACCN/A
WACC14.54%
CNNE Yearly LT Debt VS Equity VS FCFCNNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

CNNE has a Current Ratio of 1.34. This is a normal value and indicates that CNNE is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of CNNE (1.34) is better than 66.34% of its industry peers.
CNNE has a Quick Ratio of 1.34. This is a normal value and indicates that CNNE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.34, CNNE is in the better half of the industry, outperforming 67.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.34
Quick Ratio 1.34
CNNE Yearly Current Assets VS Current LiabilitesCNNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

3

3. Growth

3.1 Past

CNNE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.85%.
The Revenue for CNNE has decreased by -20.61% in the past year. This is quite bad
Measured over the past years, CNNE shows a very negative growth in Revenue. The Revenue has been decreasing by -15.81% on average per year.
EPS 1Y (TTM)-11.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10.84%
Revenue 1Y (TTM)-20.61%
Revenue growth 3Y-15.21%
Revenue growth 5Y-15.81%
Sales Q2Q%-7.88%

3.2 Future

The Earnings Per Share is expected to grow by 32.81% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 0.23% on average over the next years.
EPS Next Y75.36%
EPS Next 2Y32.81%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.74%
Revenue Next 2Y0.23%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CNNE Yearly Revenue VS EstimatesCNNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
CNNE Yearly EPS VS EstimatesCNNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 5 -5 10 15 20

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CNNE. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CNNE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CNNE Price Earnings VS Forward Price EarningsCNNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CNNE Per share dataCNNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

A more expensive valuation may be justified as CNNE's earnings are expected to grow with 32.81% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.81%
EPS Next 3YN/A

2

5. Dividend

5.1 Amount

CNNE has a Yearly Dividend Yield of 2.77%.
CNNE's Dividend Yield is a higher than the industry average which is at 4.93.
CNNE's Dividend Yield is comparable with the S&P500 average which is at 2.51.
Industry RankSector Rank
Dividend Yield 2.77%

5.2 History

CNNE has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CNNE Yearly Dividends per shareCNNE Yearly Dividends per shareYearly Dividends per share 2021 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

The earnings of CNNE are negative and hence is the payout ratio. CNNE will probably not be able to sustain this dividend level.
DP-7.35%
EPS Next 2Y32.81%
EPS Next 3YN/A
CNNE Yearly Income VS Free CF VS DividendCNNE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

CANNAE HOLDINGS INC

NYSE:CNNE (4/22/2025, 8:04:00 PM)

After market: 17.16 0 (0%)

17.16

+0.33 (+1.96%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)02-24 2025-02-24/amc
Earnings (Next)05-07 2025-05-07/amc
Inst Owners84.58%
Inst Owner Change-0.14%
Ins Owners8.77%
Ins Owner Change0.48%
Market Cap1.08B
Analysts86.67
Price Target25.16 (46.62%)
Short Float %1.93%
Short Ratio2.36
Dividend
Industry RankSector Rank
Dividend Yield 2.77%
Yearly Dividend0.34
Dividend Growth(5Y)N/A
DP-7.35%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-17 2025-03-17 (0.12)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-73.44%
Min EPS beat(2)-147.33%
Max EPS beat(2)0.45%
EPS beat(4)1
Avg EPS beat(4)-515.01%
Min EPS beat(4)-1308.4%
Max EPS beat(4)0.45%
EPS beat(8)1
Avg EPS beat(8)-748.44%
EPS beat(12)3
Avg EPS beat(12)-2926.22%
EPS beat(16)4
Avg EPS beat(16)-1344.21%
Revenue beat(2)2
Avg Revenue beat(2)3.71%
Min Revenue beat(2)1.74%
Max Revenue beat(2)5.68%
Revenue beat(4)3
Avg Revenue beat(4)-0.83%
Min Revenue beat(4)-14.03%
Max Revenue beat(4)5.68%
Revenue beat(8)3
Avg Revenue beat(8)-5.29%
Revenue beat(12)3
Avg Revenue beat(12)-7.46%
Revenue beat(16)5
Avg Revenue beat(16)-4.98%
PT rev (1m)-6.33%
PT rev (3m)-11.9%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-28.04%
EPS NY rev (1m)-1.48%
EPS NY rev (3m)-1.48%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.81%
Revenue NY rev (1m)-0.21%
Revenue NY rev (3m)-2.15%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.38
P/FCF N/A
P/OCF N/A
P/B 0.59
P/tB 0.61
EV/EBITDA N/A
EPS(TTM)-4.72
EYN/A
EPS(NY)-1.16
Fwd EYN/A
FCF(TTM)-1.55
FCFYN/A
OCF(TTM)-1.43
OCFYN/A
SpS7.21
BVpS29.25
TBVpS28.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.67%
ROE -16.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.97%
FCFM N/A
ROA(3y)-13.01%
ROA(5y)-1.54%
ROE(3y)-15.27%
ROE(5y)-1.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.75%
GM growth 5Y3.28%
F-Score3
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 52.63%
Cap/Sales 1.55%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.34
Quick Ratio 1.34
Altman-Z 2.08
F-Score3
WACC14.54%
ROIC/WACCN/A
Cap/Depr(3y)55.99%
Cap/Depr(5y)58.5%
Cap/Sales(3y)1.82%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10.84%
EPS Next Y75.36%
EPS Next 2Y32.81%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-20.61%
Revenue growth 3Y-15.21%
Revenue growth 5Y-15.81%
Sales Q2Q%-7.88%
Revenue Next Year-1.74%
Revenue Next 2Y0.23%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y12.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year29.64%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y0.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2.62%
OCF growth 3YN/A
OCF growth 5YN/A